OKYO Pharma Limited (OKYO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    OKYO Pharma Limited

    NASDAQ: OKYO · Real-Time Price · USD
    2.26
    0.01 (0.44%)
    At close: Sep 05, 2025, 3:59 PM
    2.26
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    OKYO Pharma Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 2.56K 7.51K 3.8K 2.42K 13.09K
    Gross Profit
    		 -2.56K -7.51K -3.8K -2.42K -13.09K
    Operating Income
    		 -7.19M -15.69M -13.19M -6.23M -4.13M
    Interest Income
    		 5.47K n/a n/a n/a n/a
    Pretax Income
    		 -7.97M -16.8M -13.28M -6.22M -3.38M
    Net Income
    		 -4.71M -16.82K -13.27M -5.43M -3.35M
    Selling & General & Admin
    		 4.93M 7.45M 6.75M 4.93M 2.97M
    Research & Development
    		 2.25M 8.24M 6.34M 1.61M 348.35K
    Other Expenses
    		 n/a -15.68M -527 -320K 43.65K
    Operating Expenses
    		 7.19M 8.24K 13.08M 6.22M 3.37M
    Interest Expense
    		 883.65K 1.05M 96.69K n/a 1.12K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a
    Cost & Expenses
    		 7.19M 15.75M 13.19M 6.22M 3.37M
    Income Tax Expense
    		 -3.26M 22.41K -12.2K -787K -24.99K
    Shares Outstanding (Basic)
    		 39.49M 29.34M 22.26M 15.06M 10.35M
    Shares Outstanding (Diluted)
    		 39.49M 29.34M 22.26M 15.06M 10.35M
    EPS (Basic)
    		 -0.12 -0.00 -0.6 -0.36 -0.32
    EPS (Diluted)
    		 -0.12 -0.00 -0.6 -0.36 -0.32
    EBITDA
    		 -7.08M -15.75M -13.18M -6.21M -3.35M
    EBIT
    		 -7.09M -15.75M -13.19M -6.22M -3.37M
    Depreciation & Amortization
    		 2.56K 3.87K 3.8K 2.33K 13.11K

    Add to Watchlist